BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Psoriatic arthritis clinical trials and catalysts
Active industry-sponsored trials on ClinicalTrials.gov for psoriatic arthritis: 66 (33 sponsors; 9 newly posted in the last 180 days, 1 stopped in the last 180 days; 3 new-entrant sponsors). Momentum score 31.8, rank 4 of 91 on the disease-area ranking. As of 2026-11-18.
Phase distribution: Early Phase 1 0, Phase 1 7, Phase 2 10, Phase 3 30, Phase 4 5, N/A 14.
Most active sponsors, by phase
| Sponsor | Active trials | By phase | New (window) | Upcoming readouts |
|---|---|---|---|---|
| Janssen Research & Development, LLC | 9 | P2 1, P3 5, P4 2, NA 1 | 1 | 2 |
| Bristol-Myers Squibb BMY | 4 | P3 4 | 1 | 0 |
| Takeda TAK | 4 | P3 4 | 1 | 0 |
| AbbVie ABBV | 6 | P3 3, NA 2, P2 1 | 0 | 0 |
| MoonLake Immunotherapeutics AG MLTX | 3 | P3 3 | 0 | 1 |
| UCB Biopharma SRL | 4 | P1 2, P3 2 | 0 | 1 |
| Amgen AMGN | 3 | P3 2, P1 1 | 1 | 1 |
| Eli Lilly and Company LLY | 3 | P3 2, P4 1 | 0 | 0 |
| Sun Pharmaceutical Industries Limited | 2 | P3 2 | 0 | 0 |
| Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 1 | P3 1 | 0 | 0 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 | P3 1 | 0 | 1 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 1 | P3 1 | 0 | 0 |
| Novartis Pharmaceuticals NVS | 5 | P2 2, P1 1, NA 2 | 2 | 1 |
| Adelphi Real World | 1 | NA 1 | 0 | 0 |
| AndHealth | 1 | NA 1 | 0 | 0 |
| CARE ARTHRITIS LTD. | 1 | P4 1 | 0 | 0 |
| Celltrion | 1 | NA 1 | 0 | 1 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 1 | P2 1 | 0 | 0 |
| Chongqing Genrix Biopharmaceutical Co., Ltd | 1 | NA 1 | 0 | 0 |
| Clarent Biopharma, Inc. new entrant | 1 | P2 1 | 1 | 1 |
| Dr. Reddy's Laboratories Limited, India new entrant | 1 | P1 1 | 1 | 1 |
| Forward Therapeutics FWRD new entrant | 1 | P2 1 | 1 | 0 |
| InventisBio Co., Ltd | 1 | P2 1 | 0 | 0 |
| Janssen Pharmaceutica N.V., Belgium | 1 | NA 1 | 0 | 0 |
| Janssen Scientific Affairs, LLC | 1 | NA 1 | 0 | 0 |
New-entrant sponsors: Clarent Biopharma, Inc., Dr. Reddy's Laboratories Limited, India, Forward Therapeutics.
Recently stopped trials
- NCT06431750 Novartis Pharmaceuticals - withdrawn: Sponsor decision Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juveni
Upcoming trial readouts (next 90 days)
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-12-13 est. | P3 | Jiangsu HengRui Medicine Co., Ltd. | NCT04957550 To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis | Psoriatic Arthritis | active not recruiting | 418 |
| 2027-02-17 est. | P2 | Merck Sharp & Dohme LLC MRK | NCT07486960 Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) | Psoriatic Arthritis | active not recruiting | 140 |
Readouts in the last 180 days
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-10-31 est. | P2 | Spyre Therapeutics, Inc. SYRE | NCT07148414 A Study of SPY072 in Rheumatic Disease | Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Rheumatic Diseases; Rheumatic Jo | active not recruiting | 285 |
| 2026-09 est. | P3 | AbbVie ABBV | NCT06100744 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Recei | Juvenile Psoriatic Arthritis | recruiting | 40 |
| 2026-06-05 | P3 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis | Psoriatic Arthritis | active not recruiting | 208 |
| 2026-05-26 | P3 | UCB Biopharma SRL | NCT04009499 A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis | Psoriatic Arthritis | completed | 1131 |
Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "psoriatic arthritis"); readouts matched by condition text. Registry counts only; not a forecast.
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.